About the Company
Vertex, Inc. is a tax compliance software and services company based in King of Prussia, Pennsylvania, USA. Vertex was founded in 1978 by Ray Westphal. Jeff Westphal, Stevie Westphal Thompson and Amanda Westphal Radcliffe purchased interest in the company from their father in 2000. On July 29, 2020, the company went public on the Nasdaq stock exchange.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Vertex, Inc.
Vertex Inc.: Moving To The Sidelines As Near-Term Growth Expectations Get Reset
Additionally, there was a pronounced slowdown in customers’ own business growth. This is also problematic because this means ...
Vertex (VERX) Hits New Low on Tempered Growth Outlook
We recently published 10 Stocks Taking the Worst Hit. Vertex Inc. (NASDAQ:VERX) is one of the worst-performing stocks on ...
Vertex, Inc. Navigates Growth Amid Challenges
Detailed price information for Vertex Inc Cl A (VERX-Q) from The Globe and Mail including charting and trades.
Vertex, Inc. to Announce Fourth Quarter 2024 Financial Results on ...
Vertex, Inc., a leading provider of indirect tax solutions, announced it will release its financial results for the fourth quarter of 2024 on February 27, 2025, before the market opens.
These Analysts Slash Their Forecasts On Vertex After Q2 Results
Vertex reported quarterly earnings of 15 cents per share which beat the analyst consensus estimate of 14 cents per share. The ...
Vertex, Inc. Reports Strong Q1 2025 Financial Results and ... - Nasdaq
Vertex, Inc. reported its first-quarter financial results for 2025, showing total revenues of $177.1 million, a 12.9% year-over-year increase, driven by a 14.4% rise in software subscription revenues.
Vertex Report: U.S. Sees Continued Acceleration in Sales Tax Rates and Rules Changes
Detailed price information for Vertex Inc Cl A (VERX-Q) from The Globe and Mail including charting and trades.
Vertex Falls After FDA Doubts Broad Use of Chronic Pain Drug
Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...
Similar Companies
Loading the latest forecasts...